Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Cancer Vaccines Market - Segmented by Type, Technology, End User & Geography (2016-2021) - Research and Markets

Research and Markets
Posted on: 03 Oct 17

The "Global Cancer vaccines market - segmented by type, technology, end-user and geography (2016 - 2021)" report has been added to Research and Markets' offering.

Analysts forecast the global cancer vaccines market to grow at a CAGR of 12-18% over the period 2015-2020.

The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many global companies are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.

Key Market Drivers:

  • Increasing cancer cases
  • Technological developments
  • Drug innovations with regard to the cancer
  • Government initiatives
  • Rise in aging populace
  • Advanced health care services
  • Upsurge in awareness about cancer and their available therapies in the market
  • Increasing health care expenditure

Companies Mentioned:

  • AstraZeneca plc
  • Aduro BioTech
  • Cytos
  • Galena Biopharma
  • Juvaris Biotherapeutics
  • MedImmune
  • Oxford BioMedica
  • Prima BioMed
  • GlaxoSmithKline
  • Sanofi
  • Merk&co
  • Ubivac
  • Vaccinogen

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Introduction

4. Market Overview

5. Porters Five Force Analysis

6. Market Segmentation

7. Competitive Landscape

8. Company Profiles

9. Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 03/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.